Literature DB >> 8358430

Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene.

L A Sabouri1, M S Mahadevan, M Narang, D S Lee, L C Surh, R G Korneluk.   

Abstract

Myotonic dystrophy (DM) results from the amplification of an unstable CTG repeat in the 3' untranslated region of a transcript encoding a putative serine/threonine kinase. We have analysed the amplification of the repeat and the steady state levels of the DM kinase (DMK) mRNA in tissues and cell lines from normal and congenital DM individuals. Southern blot analysis of DNA samples from a severely affected neonate shows somatic heterogeneity of the repeat in all tissues studied. RNA analyses on these tissues show a marked increase in DMK steady state mRNA levels. We demonstrate that the mutant DMK allele is expressed regardless of the number of CTG repeats and that the increase in DMK mRNA levels is due to elevated mutant mRNA levels. We postulate that elevated DMK levels explains the dominant inheritance pattern of DM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358430     DOI: 10.1038/ng0793-233

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  34 in total

1.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes.

Authors:  M G Hamshere; E E Newman; M Alwazzan; B S Athwal; J D Brook
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts.

Authors:  B M Davis; M E McCurrach; K L Taneja; R H Singer; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.

Authors:  Marka van Blitterswijk; Mariely DeJesus-Hernandez; Ellis Niemantsverdriet; Melissa E Murray; Michael G Heckman; Nancy N Diehl; Patricia H Brown; Matthew C Baker; NiCole A Finch; Peter O Bauer; Geidy Serrano; Thomas G Beach; Keith A Josephs; David S Knopman; Ronald C Petersen; Bradley F Boeve; Neill R Graff-Radford; Kevin B Boylan; Leonard Petrucelli; Dennis W Dickson; Rosa Rademakers
Journal:  Lancet Neurol       Date:  2013-09-05       Impact factor: 44.182

5.  Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)?

Authors:  C Abbruzzese; R Krahe; M Liguori; D Tessarolo; M J Siciliano; T Ashizawa; M Giacanelli
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

6.  Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells.

Authors:  A A Benders; P J Groenen; F T Oerlemans; J H Veerkamp; B Wieringa
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 7.  Myotonic dystrophy: molecular and cellular consequences of expanded DNA repeats are elusive.

Authors:  P N Strong; B S Brewster
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

Review 8.  Simple tandem DNA repeats and human genetic disease.

Authors:  G R Sutherland; R I Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 9.  The molecular basis of genetic dominance.

Authors:  A O Wilkie
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

10.  Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat.

Authors:  A Jaspert; R Fahsold; H Grehl; D Claus
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.